Author:
Tang Nikki,Ratner Desiree
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Dermatology,General Medicine,Surgery
Reference77 articles.
1. Unanticipated [LINE SEPARATOR]toxicities from anticancer therapies: survivors perspectives.;Gandhi;Support Care Cancer,2010
2. . BRAF and RAS mutations in human lung cancer and melanoma.;Brose;Cancer Res,2002
3. Cutaneous toxicities of RAF inhibitors.;Anforth;Lancet Oncol,2013
4. . BREAK-2: a phase IIA trial of the selective BRAF kinase inhibitor GSK2118436 in patients with BRAF mutation-positive (V600EK) metastatic melanoma.;Trefzer;Pigment Cell Res,2011
5. . Improved survival with vemurafenib in melanoma with BRAF V600E mutation.;Chapman;N Engl J Med,2011
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献